# Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

Study · id `cardio:ct-nct04628325` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04628325](<https://clinicaltrials.gov/study/NCT04628325>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04628325

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.

## Technical summary

Registry record NCT04628325. Randomized; single masking; primary purpose treatment. Start 2017-03-01 (actual); primary completion 2019-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 136 participants (enrolled count; ClinicalTrials.gov record NCT04628325, source copy `cardio:ctgov-nct04628325-2020-11-13`, retrieved 2026-10-26)
- Started: 2017-03-01 (actual) (ClinicalTrials.gov record NCT04628325, source copy `cardio:ctgov-nct04628325-2020-11-13`, retrieved 2026-10-26)
- Primary completion: 2019-06-30 (actual) (ClinicalTrials.gov record NCT04628325, source copy `cardio:ctgov-nct04628325-2020-11-13`, retrieved 2026-10-26)
- Completion: 2020-05-01 (actual) (ClinicalTrials.gov record NCT04628325, source copy `cardio:ctgov-nct04628325-2020-11-13`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT04628325, source copy `cardio:ctgov-nct04628325-2020-11-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04628325-2020-11-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
- Condition: Heart Failure，Congestive
- Intervention (Drug): Furosemide
- Lead sponsor: University of Palermo
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University of Palermo (`cardio:org-university-of-palermo`)

## Provenance

Content hash: 52fc16309c0529cf4e6f002e4b566a47ceba0b95052d395eede288cf9a7eb9dd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
